Trump's Pick To Lead Health Agency Calls EpiPen Issue 'Disturbing'
Mylan came under fire last year for misclassifying its lifesaving allergy pen as a generic drug.
trump pick lead health agency call epipen issue disturbing mylan come fire year misclassifye lifesaving allergy pen generic drug